{"id":387505,"date":"2020-11-24T08:03:23","date_gmt":"2020-11-24T13:03:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387505"},"modified":"2020-11-24T08:03:23","modified_gmt":"2020-11-24T13:03:23","slug":"sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/","title":{"rendered":"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE, Nov.  24, 2020  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BncURjMCudbw4gXL5HiPtAY7hdPBR_mQq9-zkCFw7ZuV6WCAIIdu1LC_oquBxKGqrQx4SVZms0U3m0u-X4NQGKKnf0Sab2CifddLpY7-u0s4HtP6Fikpx4SSi2wa9lVlwMOXcGCQ8l02iQTSPL-NdaLNIlawZks96eCUMO8yXo87wZ4-OhEmZ-JNz4uzJLWqsSQ2D1lsPsKUbX9N4yU4fvq_JU5IN8VIiLb4hSx1l7nwikM8VB1Wafpg7iKcFwP_\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>SEngine<\/u><\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JO_z8dIi9duWRc3yHdqUdYQimDZlIqF8HsV8QBDIwStJcx1lEjYxoaeXfpX8YbnzG1D3ognd4YqIrub2y6Ja2pSKDnsTtcbYUeeYKxdFXBo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u> Precision Medicine<\/u><\/strong><\/a>, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived\u00a0tumor organoids, today announced that data from a study summarizing the predictive value of the PARIS\u00ae Test in breast cancer patients will be presented virtually as a poster session (PS04\/01) at the 2020 San Antonio Breast Cancer Symposium.<\/p>\n<p>Details related to the poster presentation are as follows:<br \/>Title: Clinical and genomic correlation of a CLIA certified organoid based functional test in breast cancer patients <br \/>Lead Author:\u00a0Astrid Margossian, MD, PhD<br \/>Senior Author: Carla Grandori, MD, PhD<br \/>Poster Session: Poster Session 4: Response Prediction Biomarkers I (PS04\/01)<br \/>Poster Session Date: December 9, 2020 at 8:00 am CT<\/p>\n<p>\n        <strong>About the PARIS\u00ae Test<\/strong>\u00a0<br \/>The PARIS\u00ae\u00a0Test is based on the capability to propagate patient-specific cancer\u00a0cells\u00a0as organoids\u00a0outside the body\u00a0and is applicable to all solid tumors\u00a0including colon, breast, lung, ovarian and pancreatic cancer. Organoids are cancer-derived cells grown\u00a0in 3D outside the body, which maintain the functionality of the original tumor as well as its genomic characteristics.\u00a0For cancers\u00a0where\u00a0a treatment\u00a0path is not clear, such as\u00a0many metastatic and recurrent cancers,\u00a0the PARIS\u00ae Test provides crucial information to\u00a0treating physicians\u00a0to\u00a0match the right drug to the right patient.<\/p>\n<p>\n        <strong>About <\/strong><br \/>\n        <strong>SEngine<\/strong><br \/>\n        <strong> Precision Medicine<\/strong><br \/>\n        <br \/>SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived organoids grown ex-vivo utilizing patient specific tumor cells.\u00a0As a spin-out from the world-renowned Fred Hutchinson Cancer Research Center, SEngine is leveraging over two decades of R&amp;D in diagnostics and drug discovery. The Company is commercializing the PARIS\u00ae Test, a next generation diagnostic test that predicts drug responses integrating knowledge of cancer genomics with organoids, robotics, and AI-driven computational tools. SEngine\u2019s CLIA certified PARIS\u00ae Test generates predictive drug sensitivity reports for patients with solid tumors. SEngine is also pursuing drug discovery via strategic collaborations with biopharmaceutical \/ pharma companies leveraging its precision oncology platform.<\/p>\n<p>Discover more at\u00a0<strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BncURjMCudbw4gXL5HiPtBlY6CeuyJkW85N_QEIlrLjHfHxa4S_2gUdENJ0CQm8hTHbx3-ysBo4te64drX9D3HWAv5FddjMz2Yli0rx0ss4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">SEngineMedicine.com<\/a><\/strong>\u00a0and follow the latest news from SEngine on Twitter at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4xP-zTiKnqm-4dlFH67mgRvOdhAMEku9MwQQsSQnHr8MhFFXTNwSGdrU0aKuNH5fOEAdF5FnC8DioXSl6-EaKLUU2Ut1UrsORYDQlcKU0dQzHMVmQJvBMTfOuDE_Zvx5NuoP2Tomti-Co3cV9VoqDKk2_jk0dYjVwg3CwcclPiVGqNbPyiXJU6knyZuNtlejm7nffZf0gbjJrQstW-NP9ST2k1OfMMtNuYc6uFOMnas=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>@<\/u><\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BncURjMCudbw4gXL5HiPtFdfzijvCFkJmGqRCgoJ2u-R0HIm-Se0-bVbqbUxtlbp7OfXKE1PFTjiaDDMlNSdaGJEYbwwdFbAPdriL2Jk2Cc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>SEngineMedicine<\/u><\/strong><\/a>\u00a0and on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5jJG7tEva_IZQ7zmSN_PdumkfnQHa-Uri-bixRapjOkdHoCFi69VOFGzwFkq8K5f-Fv7MpKgBntvGeHZc8V_yFBsvIWONXfJwDz-HCKcHhkSAH9fj0KFeTyOecQfu2ui\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>LinkedIn<\/u><\/strong><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Stephanie Carrington<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gUzLPPS58GhVIjoVV5p8P0KY2t6WQKKQaMzlFQmtSP29gQFfEsyeaC8lLxQ6fTn0436_P3Yiev2WT81ZZAY_RQHBnEBQqQWS0g2otCbpWce5_q_ypnL4QmN7cdBAAR0xYugApyQS7XAyfztNaLFqMg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>stephanie.carrington@westwicke.com<\/u><\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NxOMyxGdm2IsH_OQK8hQbHKRBRAHni6FsRo5YXD3J12ciAgIy2Cb3oWNfRP2iuJUsOOLbAvFn3pA86t3c303g_bid4RVPZaDeaPhp4qQD-HL0ZNf67U28_LqnzM9kV6xhEo0xpZkmD49HvNPFRWR-FXcWpXkCCInkeCwyGNWFlbQyybDz2vQNbOtS45DAW59T-cLnUxl1sm2nJ_0bMBf0PuH-kTI5EX6MqD4AmkK9BWa3FUIne6rBQ8_wAL-dohx-tSRhiDRjNDf9lIPytZv54h1DSwbkkWUSLL5KpcFF3C8tJ2IZlOGevMO3_ygRkUooUlWpfbrZq_wJcSCjUJzpjrntGdy6YH72CXQpPT5nqLYD0UC_cadXr4pF5nQ46uh\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/><\/a>646-277-1282\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/414aa664-9520-4a1e-a77c-74b74c1d2752\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived\u00a0tumor organoids, today announced that data from a study summarizing the predictive value of the PARIS\u00ae Test in breast cancer patients will be presented virtually as a poster session (PS04\/01) at the 2020 San Antonio Breast Cancer Symposium. Details related to the poster presentation are as follows:Title: Clinical and genomic correlation of a CLIA certified organoid based functional test in breast cancer patients Lead Author:\u00a0Astrid Margossian, MD, PhDSenior Author: Carla Grandori, MD, PhDPoster Session: Poster Session 4: Response Prediction Biomarkers I (PS04\/01)Poster Session Date: December 9, 2020 at 8:00 am CT About the PARIS\u00ae Test\u00a0The PARIS\u00ae\u00a0Test is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387505","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived\u00a0tumor organoids, today announced that data from a study summarizing the predictive value of the PARIS\u00ae Test in breast cancer patients will be presented virtually as a poster session (PS04\/01) at the 2020 San Antonio Breast Cancer Symposium. Details related to the poster presentation are as follows:Title: Clinical and genomic correlation of a CLIA certified organoid based functional test in breast cancer patients Lead Author:\u00a0Astrid Margossian, MD, PhDSenior Author: Carla Grandori, MD, PhDPoster Session: Poster Session 4: Response Prediction Biomarkers I (PS04\/01)Poster Session Date: December 9, 2020 at 8:00 am CT About the PARIS\u00ae Test\u00a0The PARIS\u00ae\u00a0Test is &hellip; Continue reading &quot;SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T13:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium\",\"datePublished\":\"2020-11-24T13:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/\"},\"wordCount\":375,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/\",\"name\":\"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=\",\"datePublished\":\"2020-11-24T13:03:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/","og_locale":"en_US","og_type":"article","og_title":"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium - Market Newsdesk","og_description":"SEATTLE, Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived\u00a0tumor organoids, today announced that data from a study summarizing the predictive value of the PARIS\u00ae Test in breast cancer patients will be presented virtually as a poster session (PS04\/01) at the 2020 San Antonio Breast Cancer Symposium. Details related to the poster presentation are as follows:Title: Clinical and genomic correlation of a CLIA certified organoid based functional test in breast cancer patients Lead Author:\u00a0Astrid Margossian, MD, PhDSenior Author: Carla Grandori, MD, PhDPoster Session: Poster Session 4: Response Prediction Biomarkers I (PS04\/01)Poster Session Date: December 9, 2020 at 8:00 am CT About the PARIS\u00ae Test\u00a0The PARIS\u00ae\u00a0Test is &hellip; Continue reading \"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T13:03:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium","datePublished":"2020-11-24T13:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/"},"wordCount":375,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/","name":"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=","datePublished":"2020-11-24T13:03:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTAyOSMzODQwNzc0IzIxOTc1MjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-data-from-predictive-value-of-paris-test-in-breast-cancer-patients-at-2020-san-antonio-breast-cancer-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SEngine Precision Medicine to Present Data from Predictive Value of PARIS\u00ae Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387505"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}